edgepedia

Life science in China, India, and Asia-Pacific

86 articles

Innovent Biologics

Innovent Biologics (信达生物) is a Chinese biopharmaceutical company founded by Yu Dechao in 2011 and headquartered in Suzhou, known for the PD-1 drug Tyvyt and the weight-loss drug mazdutide.

Jiang Rensheng

Jiang Rensheng (蒋仁生), born 1953 in Guangxi, is a Chinese businessman who founded and chairs Chongqing Zhifei Biological Products, a vaccine maker listed on Shenzhen's ChiNext board.

Jinzi Jason Wu

Jinzi Jason Wu (吴劲梓) is a pharmaceutical executive who founded Ascletis Pharma in Hangzhou in 2013, chairs it, and took it public in Hong Kong in 2018.

Jiong Lan

Jiong Lan (Lan Jiong, 兰炯) is a Chinese medicinal chemist who co-founded Shanghai biotech GenFleet Therapeutics in 2017 and leads it as CEO and general manager.

Jiuzhou Pharmaceutical

Jiuzhou Pharmaceutical (九洲药业) is a Chinese contract development and manufacturing organization founded in 1998 in Taizhou, Zhejiang, best known for supplying Novartis, its largest customer.

Jung Sang-soo

Jung Sang-soo (정상수, born 1958) is a South Korean pharmaceutical entrepreneur who founded PharmaResearch, maker of the Rejuran skin booster, and became South Korea's newest billionaire in 2025.

Kazuya Shobayashi (N.B.Medical Inc.)

Kazuya Shobayashi (正林和也) is a Japanese entrepreneur who founded N.B.Medical Inc. in Tokyo in 2021, developing neurovascular stents and in-silico device technologies; Forbes JAPAN ranked him 8th in its Japan Entrepreneurs Ranking 2026.

Khwaja Abdul Hamied

Khwaja Abdul Hamied, often cited as K. A. Hamied, was an Indian chemist and businessman who founded the pharmaceutical company Cipla in Bombay in 1935.

Kim Joo-hee

Kim Joo-hee (김주희, born 1974 in Daegu) is a South Korean biotech entrepreneur, founder and CEO of the drug-delivery company Inventage Lab, listed on KOSDAQ in 2022.

Krsnaa Diagnostics

Krsnaa Diagnostics is an Indian diagnostics company founded by Rajendra Mutha in Pune in 2010, serving 18 states through public-private partnership contracts with state governments.

Lee Sang-hoon

Lee Sang-hoon (이상훈), born 1963, is a South Korean biotech entrepreneur who founded the antibody company ABL Bio in 2016 and became a billionaire in 2025 after a $2.6 billion Eli Lilly deal.

Lee Yu-Hua

Lee Yu-Hua, also known as Yuhua Li, is a pharmaceutical scientist who co-founded Foresee Pharmaceuticals, a Taipei-based biopharmaceutical company, and serves as its Chief Technology Officer.

Li Chen (businessman)

Li Chen, also known as Chen Li, is a Shanghai-based pharmaceutical executive who founded Hua Medicine and developed the diabetes drug dorzagliatin, approved in China in 2022.

Li Ge

Li Ge (李革, also written Ge Li) is a Chinese-born American chemist who founded WuXi AppTec in 2000 and serves as its chairman and chief executive officer.

Li Ruiqiang

Li Ruiqiang (李瑞强, born 1979) is a Chinese genomics entrepreneur who founded sequencing-services provider Novogene in Beijing in 2011 after nearly nine years at BGI, where he rose to vice president.

Li Xiting

Li Xiting (李西廷), also written Xiting Li, is a Chinese-born Singapore businessman who co-founded the medical device maker Mindray in Shenzhen in 1991 and serves as its chairman and controlling shareholder.

Macleods Pharmaceuticals

Macleods Pharmaceuticals is a Mumbai-based, family-controlled Indian generics manufacturer founded in 1986, best known for anti-tuberculosis medicines, with nine plants in India and sales in more than 170 countries.

Mahesh Pratapneni

Mahesh Pratapneni is an Indian life-sciences entrepreneur who co-founded MedGenome, a Bengaluru genomic diagnostics company, in 2013, became its Group CEO in 2022, and won the EY Entrepreneur of the Year 2022 award.

Meena Ganesh

Meena Ganesh is an Indian business executive and serial entrepreneur who co-founded Portea Medical, one of India's largest home healthcare companies, in 2013 and serves as its Chairperson.

Micro Labs Limited

Micro Labs Limited is a privately held Indian pharmaceutical company founded in 1973 by G.C. Surana and led from Bengaluru by his sons Dilip and Anand Surana.

Mindray

Mindray, formally Shenzhen Mindray Bio-Medical Electronics, is a Chinese medical device manufacturer founded in Shenzhen in 1991 by Li Xiting, making patient monitors, diagnostics, and imaging equipment.

N.B.Medical Inc.

N.B.Medical Inc. (N.B.Medical 株式会社) is a Tokyo-based medical-device startup founded in October 2021 by Kazuya Shobayashi, developing neurovascular stents for cerebral aneurysms and having raised ¥3.35 billion.

Nobumasa Tsutsui

Nobumasa Tsutsui (筒井 宣政) is a Japanese medical-device entrepreneur, born in 1941 in Aichi Prefecture, who founded Tokai Medical Products and developed Japan's first domestic IABP catheter.

Park So-yeon (biotechnology executive)

Park So-yeon (박소연) is a South Korean biotechnology executive who founded Prestige BioPharma in Singapore in 2015; its Tuznue biosimilar approval made it the third Korean firm to win one in Europe.

Park Soon-jae

Park Soon-jae (박순재, born 1954) is a South Korean biotechnology entrepreneur who co-founded Alteogen in 2008, led it as chief executive until 2025, and became a billionaire.

PharmaResearch

PharmaResearch (주식회사 파마리서치) is a South Korean biopharmaceutical and cosmetics company in Gangneung, founded by Jung Sang-soo in 2001 and best known for Rejuran, a salmon-DNA skin-booster injection launched in 2014.

Pharmaron

Pharmaron (康龙化成) is a Beijing-headquartered contract research and manufacturing organization for the life sciences, founded in 2004, listed in Shenzhen and Hong Kong, and serving over 3,300 customers.

Ping Ye Zhang

Ping Ye Zhang (张叶萍) is a Chinese medical-device executive who co-founded Peijia Medical in 2012 with her spouse Dr. Zhang Yi and her sister Hong Ye.

Prenetics

Prenetics is a Hong Kong consumer health and diagnostics company co-founded by Danny Yeung in 2014. It became a major covid-19 testing provider and listed on Nasdaq in 2022.

Qiang Lu

Qiang Lu (吕强) is a Chinese biopharmaceutical executive who co-founded GenFleet Therapeutics and chairs the Shanghai company behind fulzerasib, China's first approved KRAS G12C inhibitor.